

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 536.8 |
| Log P | RDKit | 8.99 |
| Topological polar surface area (Å2) | RDKit | 71.44 |
| Number of hydrogen bond acceptors | RDKit | 4 |
| Number of hydrogen bond donors | RDKit | 1 |
| Number of carbon atoms | RDKit | 35 |
| Number of heavy atoms | RDKit | 39 |
| Number of heteroatoms | RDKit | 4 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 4 |
| Stereochemical complexity | RDKit | 0.11 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 13 |
| Number of sp3 hybridized carbon atoms | RDKit | 22 |
| Shape complexity | RDKit | 0.63 |
| Number of rotatable bonds | RDKit | 11 |
| Number of aliphatic carbocycles | RDKit | 2 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 2 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 2 |
| Number of saturated carbocycles | RDKit | 1 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 1 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 2 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 2 |
| Lipinski’s rule of 5 filter | RDKit | Failed |
| Number of Ghose filter violations | RDKit | 4 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Bad |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.211192 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.85 |
| Solubility class [ESOL] | SwissADME | Poorly soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -2.74 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 2 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | Yes |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000182 | ENSG00000023839 | ABCC2 | 1244 | ChEMBL |
| TAR_EXP_000018 | ENSG00000282301 | CYP3A7-CYP3A51P | 100861540 | ChEMBL |
| TAR_EXP_000061 | ENSG00000134538 | SLCO1B1 | 10599 | ChEMBL |
| TAR_EXP_000095 | ENSG00000224143 | EHMT2 | 10919 | NPASS |
| TAR_EXP_000280 | ENSG00000160868 | CYP3A4 | 1576 | ChEMBL, NPASS |
| TAR_EXP_000853 | ENSG00000276155 | MAPT | 4137 | NPASS |
| TAR_EXP_001520 | ENSG00000108576 | SLC6A4 | 6532 | BindingDB, ChEMBL |
| TAR_EXP_001665 | ENSG00000111424 | VDR | 7421 | NPASS |
| TAR_EXP_001629 | ENSG00000137672 | TRPC6 | 7225 | ChEMBL |
| TAR_EXP_001547 | ENSG00000275349 | SMN1 | 6606 | NPASS |
| TAR_EXP_001519 | ENSG00000142319 | SLC6A3 | 6531 | BindingDB, ChEMBL |
| TAR_EXP_001518 | ENSG00000103546 | SLC6A2 | 6530 | BindingDB, ChEMBL |
| TAR_EXP_001500 | ENSG00000021461 | CYP3A43 | 64816 | ChEMBL |
| TAR_EXP_001836 | ENSG00000144852 | NR1I2 | 8856 | ChEMBL, NPASS |
| TAR_EXP_000715 | ENSG00000044574 | HSPA5 | 3309 | NPASS |
| TAR_EXP_000473 | ENSG00000096717 | SIRT1 | 23411 | BindingDB, ChEMBL |
| TAR_EXP_000281 | ENSG00000106258 | CYP3A5 | 1577 | ChEMBL |
| TAR_EXP_000445 | ENSG00000068903 | SIRT2 | 22933 | BindingDB, ChEMBL |
| TAR_EXP_000313 | ENSG00000150768 | DLAT | 1737 | ChEMBL |
| TAR_EXP_000572 | ENSG00000108773 | KAT2A | 2648 | ChEMBL, NPASS |
| TAR_EXP_001914 | ENSG00000148344 | PTGES | 9536 | BindingDB, ChEMBL |